Post by GSK

Last week, our leaders joined #LondonTechWeek to share how GSK is harnessing tech and AI to transform how we discover, develop and deliver medicines and vaccines. Here are the key insights from our discussions: ⭐ Accelerating R&D with AI and intelligent systems: We are integrating AI-first tools and intelligent systems to significantly speed up scientific discovery. These allow researchers to analyse data, interrogate literature, and run reproducible analyses. ⭐ Revolutionising operations with digital twins: Digital twins are ensuring robust and reliable product supply. They provide end-to-end visibility across complex operations, shifting from reactive to proactive decision-making with actionable data. ⭐ Driving patient-centric AI evolution: AI is enabling a shift towards proactive and personalised healthcare. We are redesigning workflows and rigorously evaluating AI to build confidence at scale, connecting pharma insights directly to patients and clinicians. ⭐ Prioritising responsible AI use and security: As AI adoption grows, distinguishing AI model safety from traditional cybersecurity is crucial. The challenge lies in ensuring AI policy translates into practical, adaptable security measures. A huge round of applause to our GSK speakers Luke Bellamy, Eyal Itskovits, Anthony Rowe, Michael Elmore, and Shobie Ramakrishnan! #LTW26